Both options have their own sets of benefits and drawbacks, making it essential to choose the form that best fits your lifestyle and medical needs
Jones, Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Yes, it promotes energy production in the brain and body, helping reduce feelings of mental and physical fatigue
When you start semaglutide, your appetite decreases significantly, often leading to a substantial reduction in daily calorie consumption
Visible results in less than 10 days
Our professional team is available 24 hours a day, seven days a week to help customers and provide quick technology support during the whole buying process